Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: Implications for the management of polycystic ovary syndrome

Clinical Endocrinology

Volumn 66, Issue 4, 2007, Pages 513-517

  Barber, Thomas M ^a   Wass, John A H ^a   McCarthy, Mark I ^a   Franks, Stephen ^b  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; FOLLITROPIN; INSULIN; LIPID; LUTEINIZING HORMONE; SEX HORMONE BINDING GLOBULIN;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; BODY MASS; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DIET RESTRICTION; ENDOCRINOLOGY; FEMALE; GROUPS BY AGE; HOMEOSTASIS; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MENSTRUATION; METABOLIC PARAMETERS; METABOLIC SYNDROME X; METABOLISM; MORPHOLOGY; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; ANDROGENS; BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; LUTEINIZING HORMONE; METABOLIC SYNDROME X; OLIGOMENORRHEA; POLYCYSTIC OVARY SYNDROME; RETROSPECTIVE STUDIES; SEX HORMONE-BINDING GLOBULIN;

EID: 33947276374     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02764.x     Document Type: Article

References (33)

1. Apridonidze, T., Essah, P.A., Iuorno, M.J. & Nestler, J.E. (2005) Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 90, 1929-1935.
2. Berneis, K., Rizzo, M., Lazzaroni, V., Fruzzetti, F. & Carmina, E. (2007) Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 92, 186-189.
3. Dokras, A., Bochner, M., Hollinrake, E., Markham, S., Vanvoorhis, B. & Jagasia, D.H. (2005) Screening women with polycystic ovary syndrome for metabolic syndrome. Obstetrics and Gynecology, 106, 131-137.
4. Dunaif, A. (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews, 18, 774-800.
5. Dunaif, A., Segal, K.R., Futterweit, W. & Dobrjansky, A. (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 38, 1165-1174.
6. Ehrmann, D.A., Liljenquist, D.R., Kasza, K., Azziz, R., Legro, R.S. & Ghazzi, M.N. (2006) Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 91, 48-53.
7. Glueck, C.J., Papanna, R., Wang, P., Goldenberg, N. & Sieve-Smith, L. (2003) Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism, 52, 908-915.
8. Legro, R.S., Kunselman, A.R. & Dunaif, A. (2001) Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. American Journal of Medicine, 111, 607-613.
9. Talbott, E., Clerici, A., Berga, S.L., Kuller, L., Guzick, D., Detre, K., Daniels, T. & Engberg, R.A. (1998) Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study. Journal of Clinical Epidemiology, 51, 415-422.
10. Venkatesan, A.M., Dunaif, A. & Corbould, A. (2001) Insulin resistance in polycystic ovary syndrome: progress and paradoxes. Recent Progress in Hormone Research, 56, 295-308.
11. Wild, S., Pierpoint, T., McKeigue, P. & Jacobs, H. (2000) Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clinical Endocrinology, 52, 595-600.
12. The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility, 81, 19-25.
13. The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction, 19, 41-47.
14. Zawadzki, J. & Dunaif, A. (1992) Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: A. Dunaif, F.P. Haseltine, G.R. Merriam eds. Polycystic Ovary Syndrome. Blackwell Scientific, Boston, 377-384.
15. Franks, S., Gharani, N., Waterworth, D., Batty, S., White, D., Williamson, R. & McCarthy, M. (1997) The genetic basis of polycystic ovary syndrome. Human Reproduction, 12, 2641-2648.
16. Legro, R.S. (1995) The genetics of polycystic ovary syndrome. American Journal of Medicine, 98, 9S-16S.
17. Franks, S. (2006) Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. Journal of Clinical Endocrinology and Metabolism, 91, 786-789.
18. Robinson, S., Kiddy, D., Gelding, S.V., Willis, D., Niththyananthan, R., Bush, A., Johnston, D.G. & Franks, S. (1993) The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clinical Endocrinology, 39, 351-355.
19. Broekmans, F.J., Knauff, E.A., Valkenburg, O., Laven, J.S., Eijkemans, M.J. & Fauser, B.C. (2006) PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. British Journal of Obstetrics and Gynaecology, 113, 1210-1217.
20. Dewailly, D., Catteau-Jonard, S., Reyss, A.C., Leroy, M. & Pigny, P. (2006) Oligo-anovulation with polycystic ovaries (PCO) but not overt hyperandrogenism. Journal of Clinical Endocrinology and Metabolism, 91, 3922-3927.
21. Welt, C.K., Gudmundsson, J.A., Arason, G., Adams, J., Palsdottir, H., Gudlaugsdottir, G., Ingadottir, G. & Crowley, W.F. (2006) Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam Criteria: The impact of weight on phenotype and metabolic features. Journal of Clinical Endocrinology and Metabolism, 91, 4842-4848.
22. Azziz, R. (2006) Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. Journal of Clinical Endocrinology and Metabolism, 91, 781-785.
23. Powell, B.L., Haddad, L., Bennett, A., Gharani, N., Sovio, U., Groves, C.J., Rush, K., Goh, M.J., Conway, G.S., Ruokonen, A., Martikainen, H., Pouta, A., Taponen, S., Hartikainen, A.L., Halford, S., Zeggini, E., Jarvelin, M.R., Franks, S. & McCarthy, M.I. (2005) Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic ovary syndrome or related traits. Journal of Clinical Endocrinology and Metabolism, 90, 2988-2993.
24. Adams, J., Polson, D.W. & Franks, S. (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. British Medical Journal, 293, 355-359.
25. Franks, S. (1989) Polycystic ovary syndrome: a changing perspective. Clinical Endocrinology, 31, 87-120.
26. Kousta, E., Cela, E., Lawrence, N., Penny, A., Millauer, B., White, D., Wilson, H., Robinson, S., Johnston, D., McCarthy, M. & Franks, S. (2000) The prevalence of polycystic ovaries in women with a history of gestational diabetes. Clinical Endocrinology, 53, 501-507.
27. Alberti, K.G., Zimmet, P. & Shaw, J. (2006) Metabolic syndrome - a new world-wide definition: a consensus statement from the International Diabetes Federation. Diabetic Medicine, 23, 469-480.
28. Chen, M.J., Yang, W.S., Yang, J.H., Hsiao, C.K., Yang, Y.S. & Ho, H.N. (2006) Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS. Human Reproduction, 21, 2266-2271.
29. Legro, R.S., Bentley-Lewis, R., Driscoll, D., Wang, S.C. & Dunaif, A. (2002) Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity. Journal of Clinical Endocrinology and Metabolism, 87, 2128-2133.
30. Nestler, J.E. & Strauss, J.F. 3rd (1991) Insulin as an effector of human ovarian and adrenal steroid metabolism. Endocrinology and Metabolism Clinics of North America, 20, 807-823.
31. Pugeat, M., Ducluzeau, P.H. & Mallion-Donadieu, M. (2000) Association of insulin resistance with hyperandrogenaemia in women. Hormone Research, 54, 322-326.
32. Duleba, A.J., Banaszewska, B., Spaczynski, R.Z. & Pawelczyk, L. (2006) Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial. Fertility and Sterility, 85, 996-1001.
33. Lobo, R.A. (2006) Choice of treatment for women with polycystic ovary syndrome. Fertility and Sterility, 86, S22-S23.